Indeed, in a transgenic murine model of dermal fibrosarcoma, FGF2 is actively produced by fibroblasts at all stages along their malignant transformation (mild fibromatosis, aggressive fibromatosis, and fibrosarcoma) and its expression correlates with the angiogenic phenotype of the tumor (10). This evidence concerns the gene FGF2 and fibromatosis.